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Background. Absence of acquired protective immunity in endemic areas children leads to higher susceptibility to severe malaria. To
investigate the involvement of regulatory process related to self-reactivity, we evaluated potent changes in auto-antibody reactivity
proﬁles in children and older subjects living in malaria-endemic zones comparatively to none-exposed healthy controls. Methods.
Analysis of IgG self-reactive footprints was performed using Western blotting against healthy brain antigens. Plasmas of 102
malaria exposed individuals (MEIs) from endemic zone, with or without cerebral malaria (CM) were compared to plasmas from
non-endemic controls (NECs). Using linear discriminant and principal component analysis, immune footprints were compared
by counting the number, the presence or absence of reactive bands. We identiﬁed the most discriminant bands with respect
to age and clinical status. Results. A higher number of bands were recognized by IgG auto-antibodies in MEI than in NEC.
Characteristic changes in systemic self-IgG-reactive repertoire were found with antigenic bands that discriminate Plasmodium
falciparum infections with or without CM according to age. 8 antigenic bands distributed in MEI compared with NEC were
identiﬁed while 6 other antigenic bands were distributed within MEI according to the age and clinical status. Such distortion
might be due to evolutionary processes leading to pathogenic/protective events.
1.Introduction
Plasmodium falciparum infection remains a major cause
of death in most of developing countries, particularly in
sub-Saharan Africa [1]. It generates diﬀerent clinical man-
ifestations with either few or no symptoms [2]o rs e v e r e
signs such as impaired neurological function termed cerebral
malaria (CM) [3, 4]. These variable courses of the disease
have been related to diﬀerent factors such as the levels of
parasites transmitted, the age of the infected subjects, the
genetic background of the population studied [3, 4], and,
above all, the immune status of aﬀected individuals [2].
Thus, unprotected children living in endemic zones or
unprotected adults coming from nonendemic zones have a
high susceptibility to severe malaria [5].
It is postulated that partial protective immunity can be
inducedafteriterativeinfectionthroughtriggeringtheaction
of the immune response, particularly the humoral response
[6, 7]. Recent studies have highlighted the inﬂuence of the
autoantibodyresponse[8,9].Therefore,appropriateanalysis
of the serum self-IgG repertoire could contribute to a better
understanding of the immuneregulation processes involved
during the course of the disease [10].
In healthy subjects, despite of interindividual diﬀerences,
thehumanserumself-IgGresponseisthoughttobewellcon-
served and restricted to the recognition of a few self-antigens2 Interdisciplinary Perspectives on Infectious Diseases
in autologous tissues [11]. In contrast, durable distortion
of these immune proﬁles has been found in our laboratory
among patients with multiple sclerosis (MS) or other
autoimmune diseases with predominant neurological signs
such as neuropsychiatric systemic lupus erythematosus [12,
13]. When we induced experimental autoimmune enceph-
alomyelitis, dynamic changes in immune proﬁles related to
pathogenic or protective events were also identiﬁed [14,
15]. Despite the predominant neurological symptoms in
clinical and experimental situations, discriminant self-IgG
reactivity involves mostly ubiquitous antigens rather than
speciﬁc targets in nervous system tissue [16]. Although these
footprints have allowed the identiﬁcation of new useful
biomarkers [12, 13], their pathophysiological signiﬁcance
remains to be deﬁned.
In the present study, we aimed to evaluate the impact of
the environment and self-reactive natural and acquired anti-
body repertoires on humoral immune proﬁles. The ﬁndings
ofnumerousepidemiologicalandclinicalstudiessuggestthat
the risk of allergic and autoimmune diseases is related to
the hygiene hypothesis [17]. Parasitic infections, especially
malaria, may inﬂuence the development, or the course of
autoimmune disease such as MS [18]. In contrast some self-
reactive antibody responses might also inﬂuence the course
ofmalarialeadingtoprotective[8]orpathogenicevents[19].
To further evaluate the relationships between environ-
mental factors, autoimmune proﬁles, and the clinical status
of malaria, the natural and acquired self-IgG antibody
responses were analyzed in subjects of diﬀerent age brackets
living in endemic zones of parasitic transmission. Immune
proﬁles were compared between malaria patients with (cere-
bral malaria) and without (including uncomplicated disease,
asymptomatic Plasmodium falciparum carriers) neurological
symptoms. Nonimmune individuals living in countries free
of malaria were tested as controls. Our data revealed the
presence of antigenic bands speciﬁcally targeted by plasma
IgG collected in patients of a well-deﬁned clinical status and
age range. The pathophysiological signiﬁcance of such new
biomarkers is discussed.
2. Methods
2.1. Population Studied: Clinical Criteria. Plasma self-IgG
reactivity against brain tissue antigens was evaluated in 119
subjects.Bloodsampleswerecollectedfromsubjectsexposed
to malaria parasite, termed malaria-exposed individuals
([MEI] n = 102, mean age ± SD: 21.07 ± 20.2), and
from healthy subjects living in European nonendemic areas,
termed nonendemic controls ([NEC] n = 17, mean age ±
SD: 39 ± 4.5).
The MEI group was divided into two subgroups. One
subgroup consisted of patients with neurological symptoms,
usually termed cerebral malaria ([CM] n = 28, mean age ±
SD: 16.2 ± 21.4). The other subgroup was termed MEI
without neurological symptoms (n = 74, mean age ± SD:
21.1 ± 21.3) and was comprised of parasite carriers with
classical symptoms of malaria but without other compli-
cations and asymptomatic carriers (without any detectable
symptoms). MEIs with symptoms (neurological and clas-
sical) were recruited from the Emergency Department of
the University Hospital of Cocody-Abidjan (Cˆ ote d’Ivoire).
Using available data bases, plasma was classiﬁed on the basis
of World Health Organization (WHO) guidelines. Thus,
MEI with neurological symptoms included patients with
a Blantyre Coma scale ≤2 (concerning the children), a
modiﬁed Glasgow coma scale ≤9 (concerning the adult),
the occurrence of at least one convulsive episode during the
24h before admission to the emergency department, and
Plasmodium falciparum-positive thin blood smears. As ex-
pected, all of these patients were cured after quinine therapy.
Blood samples of asymptomatic parasites carriers were
obtained from the National Blood Transfusion Centre of
Abidjan, from the Mother-Infant Department of the District
Hospital, and from some volunteer students. All subjects
were included after informed consent from themselves or
from their parents. All the procedures were reviewed and
approved by the National Health Oﬃce Ethics Committee of
Cˆ ote d’Ivoire.
2.2. Population Studied: Biological Criteria. For the NEC
group, blood samples were obtained from healthy vol-
unteers following approval by the “Centre de Ressources
Biologiques-Centre d’Investigation Clinique” of CHRU-
Lille. Isolated plasmas were then stored at −40◦Ci no u r
laboratory (EA 2686, Universit´ e Lille-Nord de France).
For the MEI group, the samples were taken on the day of
admission (in the emergency department before any therapy
concerning those who were ill, the Mother-Infant Depart-
ment, the National Centre of Blood Transfusion, or in the
school for those who were asymptomatic parasite carriers).
Venous blood was collected into EDTA sterile vacutainers
(5mL). Plasma was isolated after centrifugation at 500×g
f o r1 5m i n u t e sa n ds t o r e da t−40◦C at the “Laboratoire
d’Immunologie of CHU Cocody-Abidjan” before being sent
the EA 2686 Research Group (Lille-France).
Parasitemia was assessed at the department of “Para-
sitologie-Mycologie, Facult´ ed eM ´ edecine d’Abidjan-Co-
cody-Cˆ ote d’Ivoire” as follows.
Giemsa-stained thick and thin blood ﬁlms were prepared
for detection and identiﬁcation of Plasmodium falciparum
and for parasite counts. Parasitemia is expressed as the
percentage of infected red blood cells.
Anti-falciparum total antibodies detection and quantiﬁ-
cation were performed at the “Laboratoire de Parasitologie
Mycologie-CentredeBiologie,dePathologie-CHRUdeLille-
France.” Acetone-ﬁxed Plasmodium falciparum strain 3D7
was used as antigen using indirect immunoﬂuorescence.
Brieﬂy, sera were diluted 1/100, 1/200, 1/400, 1/800, 1/1600,
and 1/3200 in phosphate-buﬀered saline (Ref 77511 Biom-
erieux). Diluted serum was incubated with acetone-ﬁxed
Plasmodium falciparum at 37◦C for 30mn. The secondary
antibody used was ﬂuorescein-conjugated goat anti-human
IgG, IgM, IgA, Heavy and Light chains-H, and L-(Ref 74511
Diagnostic Pasteur) in Bleu Evans solution (Ref 75491
Biomerieux). Any ﬂuorescence in Fluopep (Ref 75521 Biom-
erieux) obtained at a dilution 1/100 was considered negative.
Quantiﬁcation was expressed by the titre of total antifalci-
parum antibodies.Interdisciplinary Perspectives on Infectious Diseases 3
2.3. Brain Samples. Brain samples were obtained as previ-
ously described [20, 21]. Brieﬂy, cerebral tissue was extracted
by autopsy from the frontal lobe in Broadman’s area 10,
from healthy subjects with no history of neurological disease
(Department of Neuropathology, Centre Hospitalier de
l’Universit´ e de Lille, and Institut National de la Sant´ e, de la
RechercheM´ edicale,Unit´ e422,Lille,France).Autopsieswere
performed within the framework of a tissue collection pro-
gram that had been approved by the local ethics committee.
2.4. Sodium Dodecyl Sulfate—Polyacrylamide Gel Electropho-
resis (SDS-PAGE). The brain samples were homogenized in
aT r i sb u ﬀer containing 5% SDS at a ﬁnal concentration
of 10mg/mL and heated at 95◦C for 10min. 100μL of this
lysatewasloadedontoa10–20%gradientpolyacrylamidegel
(Navix Tris-Glycine Gels-Invitrogen), beside a well of 15μL
of molecular mass marker (Amersham Pharmacia Biotech).
Just before 1-dimension electrophoresis (1D), the homoge-
nates were reduced for 10min with 10mM DTT (Sigma-
Aldrich) at 100◦C. Then electrophoresis was run in Laemmli
buﬀer using the following conditions: run time 2h at
constant125Vand30–40mA/gel(start);8–12mA/gel(end).
2.5. Western-Blot Analysis. Proteins were transferred onto
ECL nitrocellulose membranes (Amersham Pharmacia
Biotech) at 0.8mA/cm2 and later saturated with 5% fat-
free dried milk. Nitrocellulose membrane was cut into 15–20
strips, 3 to 4mm wide. Western blotting was conducted with
total sera, diluted 1/100 in TNT (100mM Tris—pH 8.3-,
0.3M NaCl containing 0.5% Tween) and 5% fat-free dried
milk. Reaction IgG antibodies were revealed with an anti-
human Fcγ HRP-conjugated antibody (1/10000; Sigma-
Aldrich) after overnight incubation at 4◦C. Fluorograms
were prepared using an enhanced chemiluminescence kit
(Amersham Pharmacia Biotech Europe). Immune proﬁles
were analyzed when 2 independent assays had produced
identical patterns. Image analysis was performed on a
Molecular Imager GS-800 Calibrated Densitometer (Bio-
Rad) to localize and compare the IgG immune proﬁle
patterns. Band detection, alignment, and matching of the
antibody reactivities were performed using Phoretix 1D and
1D Pro software version 10 (Totallab-Nonlinear Dynamics)
and validated by two operators. We performed comparative
analyses using detection-band parameters that allowed us
to consider each band intensity that was >13% higher than
the global background intensity of the gel to be signiﬁcant.
To calibrate and more accurately deﬁne the alignment
of antibody reactivities, molecular weight marker protein
standards (StdMW-Benchmark Pre-Stained Protein Ladder,
Invitrogen) as well as internal reference standards were used.
The level to which each molecular standard migrates is called
relative front of migration (RF). A function curve deﬁned by
RFvaluesontheX axisandstandardmolecularweightonthe
Y axis allowed the molecular weight of each antigenic band
to be determined by extrapolation because the reactive band
a l i g no ni t sR F .
2.6. Statistical Analysis. Data were expressed in binary mode
(0 = absence of an antigenic band and 1 = presence of an
antigenic band) for submission of IgG antibody patterns for
analysis using either the chi-square test or Fisher’s exact test.
This approach allowed us to select the most relevant antigens
thatqualitativelysupporteddiﬀerenttypesofimmunerecog-
nition. We then used linear discriminant analysis (LDA) to
balance the discriminating antigens between the populations
of individuals, as described previously [22, 23]. Using a
stepwise logistic regression model and supported by the LDA
method, we isolated a subgroup of brain antigens according
to their strength of discrimination between the diﬀerent
populations involved in the study. Using 2 parameters (for
the presence—1—or absence—0—of each selected antigen)
and the coeﬃcient previously deﬁned by the LDA, a score
was calculated for each subject as a representative value of
the individual immune proﬁle, using the following formula:
Score = Ag1coef1 ×

0(absent) or 1

present

+A g2 c oe f 2×

0(absent)or 1

present

+A g3 c oe f 3 ,
(1)
where Ag represents antigen and coef represents coeﬃcient.
The calculated scores were then represented graphically.
A threshold value was determined using a receiver operating
characteristic curve, and the sensitivity and speciﬁcity of
this approach were evaluated. When the number of patients
was too small to apply LDA, chi-square and Fisher’s exact
tests were performed to retain the most discriminant band.
To compare the number of bands between the diﬀerent
groupsofsubjects,weusedthechi-squaretest.Thefrequency
of each discriminant self-reactive band has been calculated
determining its percentage of its presence within the group
of subjects.
Usingprincipalcomponentanalysis(PCA)andnonpara-
metric test of Kruskal-Wallis, we evaluated the relationship
between the discriminant band and the clinical status.
3. Results
3.1. Comparative Analysis of Self-IgG Patterns Obtained in
Subjects Living in Endemic or in Nonendemic Areas for
Plasmodium falciparum Infection. Self-IgG reactivity against
human brain was compared between patterns obtained with
plasma samples from the MEI group, with or without
neurologicalsymptoms(subjectsfrom1to86yearsold),and
those obtained with samples from the NEC group (Figure 1).
Self-IgG responses appeared to be quantitatively (number
of bands) and qualitatively (presence or absence of bands)
heterogeneous within or between the diﬀerent populations
studied.
Quantiﬁable data were given after the mapping and
alignment of all patterns which revealed 4 to 19 bands
according to the strips. When all of the strips were consid-
ered, there were more antigenic bands in the MEI (n = 102,
mean ± SD: 14.9 ± 3.9) than in NEC group (n = 17, mean
4.7 ± 1.9; P<0.0001). Comparison of subjects within the
MEI group did not reveal any signiﬁcant diﬀerences (MEI
with neurological symptoms, n = 28, mean: 14.2 ± 3.8; MEI
without neurological symptoms, n = 74, mean: 15.45 ±3.9).
Furthermore, no correlation was found between the number4 Interdisciplinary Perspectives on Infectious Diseases
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Figure 1: Representative IgG autoreactive patterns obtained with plasma from subjects living in malaria endemic area. The tested plasmas
were obtained from malaria-exposed individuals (MEIs) with or without neurological manifestations, of all ages (from 1 to 86 years old).
In parallel nonexposed healthy subjects called nonendemic controls (NECs) were also evaluated. For these western blot analyses, protein
extracts of the central nervous system (CNS) tissue collected in one subject with no history of neurological disease were used as antigenic
targets. Despite the heterogeneous band patterns, comparison of the strips allowed identiﬁcation of some singular antigenic bands. Some
bands were shared by diﬀerent groups of subjects (vertical arrows). In contrast, other bands were speciﬁcally found in some groups of
subjects (diagonal arrows). As illustrated, p94 and p43 protein bands were speciﬁcally found in either MEI with neurological symptoms or
in MEI without neurological symptoms.
of protein bands within MEI and the titre of antifalciparum
antibodies evaluated by the procedure described in materials
and methods (parametric test of Pearson used for MEI with
neurological symptoms, P = 0.625 and in MEI without
neurological symptoms, P = 0.974).
For qualitative analysis, the presence or the absence of
each protein band for all bands identiﬁed in the 119 strips
(n = 42) was evaluated on each strip. Despite interindividual
diﬀerences, some conserved sets of protein bands were
found. As indicated in Figure 1, common responses were
noted either in the same group (MEI with neurological
manifestations) or between distinct groups (MEI with neu-
rological symptoms, MEI without neurological symptoms,
and NEC).
3.2. Identiﬁcation of Discriminant Antigenic Bands
Targeted by Self-IgG
3.2.1. Related to the Clinical Status. After chi-squared and
Fisher analyses, 8 antigenic bands (p180, p94, p74, p64,
p58, p35, p22, and p19) showed a diﬀerent distribution
in MEI versus NEC. The coeﬃcient value determined by
LDA for each discriminatory antigenic band associated with
the presence or absence of these antigens allowed us to
calculate the graphic coordinates for each subjects. As shown
in Figure 2, the score assigned to each subject revealed three
distinctive areas according to each group. We also observed
that the NEC group was largely distinct from the MEI group.
3.2.2. Related to Age. Age is already known to inﬂuence the
course of malaria infection [5]. We therefore considered the
parameter of age with arbitrary distinction of 4 age brackets
(1–5, 6–15, 16–30, and >30 years) to detect any antigenic
bands that discriminate between malaria with or without
neurological symptoms.
Chi-square, Fisher, and LDA analyses were performed
to discriminate between MEI with or without neurological
symptoms for each of the deﬁned age groups. For ages over
30 years, LDA combined with Fisher and chi-square tests
did not identify any discriminatory antigenic bands, in MEI
with or without neurological symptoms. However, for ages
under 30 years, LDA and Fisher tests identiﬁed the two
most discriminant antigenic bands in MEI with or without
neurological symptoms (with P<0.250) per age group (1–5
years: p130 and p30; 6–15 years: p180 and p43; 16–30 years:
p94 and p74). As shown in Figure 3, comparative chi-square
analyses (with P<0.05) of band frequencies showed no
discriminatory bands to be coexpressed in two age groups.
Therefore, this excludes frequency changes related to age
and clinical status. Only the p94 and p74 antigenic bands
(Figure 1) are expressed in 100% of MEI subjects aged toInterdisciplinary Perspectives on Infectious Diseases 5
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Figure 2: Identiﬁcation of antigenic bands discriminating MEIs with or without neurological manifestations and NECs. (a) Schematic
representation of 1 western-blot strip, showing the 8 healthy brain antigenic bands (characterized by their molecular weight) that reveal
discriminatory immune reactivities with sera from MEI with or without neurological manifestations and NEC. The coeﬃcient values
assigned by linear discriminant analysis (LDA; coeﬃcients for the x axis and y axis) are speciﬁed for each antigenic band. (b) Graphic
extrapolation of the LDA data, obtained from the plasma tests of the 3 clinical groups of subjects revealed three distinct zones in which the
NEC subjects were clearly separate from MEI.
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Figure 3: Evolution of IgG autoreactive patterns related both to age
groups and clinical status within MEI. In each age group, distinct
discriminantantigenicbandswerefound:p130andp30(1–5years),
p180 and p43 (6–15 years), and p94 and p74 (16–30 years). The
respectivefrequenciesofthesebandsweregivenforMEIwith(black
diagram) or without (grey diagram) neurological manifestations.
16–30 years with neurological symptoms. Only the p43
antigenicband(Figure 1)wasexpressedinMEIsubjectsaged
to 6–15 years old.
To conﬁrm a tight relationship between MEI with
neurological symptoms or CM, a complementary LDA
was performed which accounts for the occurrence of CM
irrespective of the age of MEI. Three bands including p94,
p140, and p145 were then identiﬁed (data not shown) to
discriminate between CM (1–5 years old), CM (6–15 years
old), and CM (16–30 years old). The 2-dimensional PCA
shown in Figure 4 indicates p94 as the best biomarker for a
well-deﬁned clinical status within a well-deﬁned age range
(Kruskal-Wallis test: P = 0.001).
4. Discussion
Plasmodium falciparum underlies most cases of severe and
fatal malaria. Among the complications of this preeminent
tropicalparasiticdisease,CMandsevereanemiaarethemost
common causes of death, especially in children under the
age of ﬁve years, and in pregnant women and malaria-na¨ ıve
individuals [24]. Although the risk factors that predispose
individuals to develop CM are still largely unknown [25],
the lack of premunition deﬁned by the antimalarial immune
response is often evoked [4]. These data underline how the
capacity of the immune system plays a critical role in patho-
physiological events associated with malaria. In our study,
we focused on some properties of the humoral response
by studying the repertoire of self-reactive IgG antibodies.
Changes in the humoral response in malaria have been
previously characterized by high plasma levels of IgG and
IgM antibodies [26, 27] although only a small proportion of
theseantibodiesaredirectedagainstmalariaantigens[28].In
contrast,highfrequenciesofautoantibodieswithspeciﬁcities
comparable with those associated to autoimmune diseases
have been also described in this context [9]. The exact causes6 Interdisciplinary Perspectives on Infectious Diseases
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Figure 4: Relationship between p94 antigenic band and MEI
with neurological manifestations. A two-dimensional principal
component analysis (PCA) of all MEI with neurological mani-
festations (termed cerebral malaria-CM) aged from 1 to 30 years
was evaluated. The biplot of the data (PC 1 = x-axis versus PC
2 = y-axis) displays the correlation between the expression of the
discriminatory bands (shown as lines) and the age group of CM
patients (in italics for 1–5 years; in bold for 6–15 years; in normal
characters for 16–30 years). For each patient, data dispersions were
represented by the barycentre (). The position of the invidious
relative to the three discriminant bands (shown as lines) reveals
their relationship. In this view, p94 appears to be the best marker
associated with CM aged to 16–30 years.
and consequences of natural and/or acquired autoimmune
responses associated with malaria infections remain to be
deﬁned. In the present study, we evaluated the global
self-reactive IgG antibody patterns against brain antigens
obtained with plasma from 102 individuals living in high
perennial transmission area (malaria exposed individuals or
MEIs) with or without CM. We compared these with the
IgGantibodypatternsagainstbrainantigensfromtheplasma
samples of 17 nonexposed healthy subjects (nonendemic
controls, NECs).
A comparative analysis of all patterns obtained regardless
of the subjects’ age (range from 1 to 86 years old) allows
us to ﬁrst discuss the signiﬁcance of observed quantitative
changes. The MEI group showed a higher number of
antigenic bands detected by plasma IgG compared with the
NEC group. This could be due to a higher external antigenic
stimulation in MEI with a polyclonal B cell activation
inducedbyparasitesactingasmitogens[29,30]withapotent
eﬀect on the natural and acquired antibody repertoire. Such
an elevated self-IgG reactivity may be also related to the
parasitic genetic diversity with a possible process of molec-
ular mimicry [31]. Indeed, Plasmodium falciparum has been
shown to have considerable genetic diversity, which is
facilitated by the haploid state of all plasmodial stages in
the human host. This genotypic variability is expressed by a
microgeographical heterogeneity of the parasite [31]. In CM,
the antiplasmodial antibodies induced may react directly
against the numerous parasite-derived antigens and cross
react against a few epitopes expressed on brain parasite-
induced endothelial microparticles [32, 33]. In addition,
brain endothelial-derived microparticles with the properties
of cell-adhesion molecules are increased in patients with
malaria [34–37] and can be also recognized as autoantigens.
Thus, shared epitopes between parasite-infected erythrocyte
surface molecules and self-host antigens may be targeted
by antifalciparum antibodies and can lead to increased self-
immune reactivity against the brain extract tissues used in
our Western-blot tests. In contrast to a previous study [38],
we found no correlations between the number of protein
bands recognized by self-IgG antibodies to brain antigens
and the titer of total antifalciparum antibodies. Speciﬁc
antibodies quantiﬁed by Elisa were detected against only
some representative parasitic antigens [38]. In our work, we
have tested antibody response against surface antigens (data
not shown). It would be of interest to further evaluate IgA
and IgM self reactivities against brain antigens to estimate
a potent correlation with speciﬁc response against parasite
antigens. Beside the question of distinct methodological
approaches (large spectrum of aﬃnity for detected IgG in
western blot, restricted high aﬃnity for speciﬁc antibodies
against Plasmodium falciparum antigens evaluating IgG but
also IgA and IgM isotypes); such data suggest a possi-
ble involvement of natural and/or acquired autoantibody
responses in the observed patterns. The participation of the
natural autoantibody repertoire is also suggested by some
protein bands commonly recognized by all tested plasmas
(MEI and NEC groups). Previous data underlined the pres-
ence of such consensual immune patterns of self-recognition
deﬁned as immunological homunculus [39–41].
A comparative analysis of all patterns, obtained whatever
the age of the subjects, allows us to also discuss the signiﬁ-
canceofobservedqualitativechanges.Indeed,highinterindi-
vidual diﬀerences in autoreactivity are found among all
tested subjects. There is an additional problem linked to
the genetic control of such a response, thus, causing a huge
variability in terms of population genetics. Nevertheless, in
spite of such degree of heterogeneity with regard to the
number and the nature of the protein bands recognized, the
statistic analysis of such qualitative changes allowed us to
clearly diﬀerentiate the three groups of tested subjects (MEI
with or without CM and NEC) with high sensitivities and
speciﬁcities. Thus, we deﬁned 8 brain antigens diﬀerentially
represented in the MEI group compared to the NEC group;
and 6 other brain antigens diﬀerentially represented inside
the MEI group in relation, the age (before 30 years old)
and to the clinical status (with or without CM). Such
distortion of the global systemic self-IgG-reactive reper-
toire might be caused by variable events inducing changes
in natural or adaptive tolerance. Indeed, humoral innate
responseswithnaturalautoantibodies,detectedinabsenceof
knownimmunization[39,40],provideimmediateandbroad
protection against pathogens but also participate in the
establishment of the natural tolerance [40]. Recent data have
shown relationships between the activation of TLRs and the
production of natural antibodies. Upon TLRs signals, hyper
somatic mutation and class-switch recombination have beenInterdisciplinary Perspectives on Infectious Diseases 7
demonstrated [42]. Thus, exogenous (Plasmodium infec-
tion) but also endogenous factors (events related to malaria
pathogenesis) might induce the breakdown of natural toler-
ance mechanisms with or without evident symptoms [14]
even if it has been reported that autoimmune responses
may also play a role in the protective immune process in
malaria [8].
To more precisely deﬁne the factors involved in the
changes, the two MEI subgroups (MEI with or without
CM), we considered the parameter of age using an arbitrary
distinction of 4 age brackets (1–5, 6–15, 16–30, and >30
years). Age inﬂuences the severity of the infection since it is
known that malaria in children living in endemic zones is
often severe. They are the ﬁrst victims of CM because of their
unprotected immune status [5, 43, 44]. In our study, two
types of singular self-IgG reactivity were noted (common or
discriminatoryantigenicbands)whenweexaminedthethree
youngest age groups of MEI with or without neurological
signs (1–5 years, 6–15 years, and 16–30 years). The lowest
number of MEI with CM was for the subgroup aged over 30
yearsanddoes notallowustodiscussthe resultsobtained for
this age group. However, all self immune prints from MEI,
with or without neurological symptoms, were superimposed
in this age bracket. These data on self-reactive prints suggest
that during parasitic infection of adults, there is a point
where stop-evolving events appear. During aging, internal
changes in self-proteins may occur, and the general network
of natural autoantibodies called “Immunculus” [45]w i l l
be also modiﬁed [46]. Furthermore, some internal events
(metabolic deviations related to diseases) and external events
(environmental factors) could lead to “immunculus” distor-
tions. Common antigenic bands (p49) appeared in MEI age
groups from 1 to 30 years irrespective of clinical status. This
nondiscriminatory reactivity might be linked to the previ-
ously described “immunculus” characterized by constant or
minimalindividualvariationsoftheimmunerepertoire[45].
These natural autoantibodies derived from human germline
immunoglobulin genes without somatic mutations are often
poly reactive and expressed a low aﬃnity for antigens [39,
40, 47]. Natural autoantibodies in diﬀerent members of a
malaria population may also react against the conserved
public self-epitopes [9, 48–50]. In return, the microbial,
viral, and parasitic infections can all modify the antibody
repertoire leading to the emergence of potent pathogenic
auto-antibodies [51]. Natural and acquired auto-antibodies
are often directed against ubiquitous antigenic targets with
diﬀerent seric titers, that is, antinuclear, antimuscle, or
antiphospholipid, antibodies. Nevertheless, they occur at
higher frequencies among individuals exposed to viral, bac-
terial, and parasitic diseases, including malaria [9, 40].
In our work, some speciﬁc antigenic bands, presented
as a peculiar intragroup self-reactivity pattern, are expressed
according to each age group in diﬀerent proportions in MEI
with or without CM. In children aged 1 to 15 years, discrim-
inant antigenic bands were identiﬁed (p130-p30 in subjects
aged from 1 to 5 years, and p180-p43 in subjects aged from 6
to15years).However,theyarenotgoodbio-markersforCM,
as they were low in frequency within each age group of MEI
with CM. In contrast, in MEI subjects aged from 16 to 30
years, signiﬁcant discriminatory bands were found. Subjects
of this group displayed singular self-immune reactivity—
characterized by only two discriminatory self-reactive anti-
genicbands—p94andp74—whenthepresenceorabsenceof
CM is taken into account. This appears stable in all subjects
since they were immunized against almost all prevalent
parasitic strains encountered in the area [4, 52, 53]. When
we considered only the presence of CM irrespective of age,
three antigenic bands were identiﬁed (p145, p140, and p94).
A double band localized at p147KDa has been previously
detectedandcharacterizedasisoformsofnonerythroidspec-
trin [38]. Regarding the degree of resolution of our method-
ological approach of we cannot exclude that p140, p145,
and p147 could be the similar antigenic targets. The p94
band is of particular interest. It discriminated, not only MEI
andNEC,butalsoitdiscriminatedbothMEIwithorwithout
neurologicalsymptomsandCMpatientsaccordingtoage.As
previously postulated, this new discriminant antigenic target
could be a fraction of the p147 band, cleaved during apop-
tosis following the activation of a neutral calcium-activated
protease (calpain) [54]. Such dynamic changes occurring
before and after 16 years might be related to the immune
response against diﬀerent strains of Plasmodium falciparum
that underlie recurrent infections. Indeed, in malaria-
endemic zones, acquired protective immunity (called pre-
munition) induced by parasitic diversity is strengthened
with increasing age [55–57]. Consequently, in children,
iterative infection episodes may induce antibodies to speciﬁc
parasitic strains which can cross-react against self-epitopes.
Furthermore, these recurrent parasitic attacks occurring
in childhood may induce inﬂammatory and deleterious
tissue events. This may generate neoantigenicity by epitope
spreading processes [58], or by revealing self cryptic/hidden
antigens [14, 15, 59], thereby, favoring expression of new
antibodies involved in self-immune reactivity and potent
pathophysiological events.
5. Conclusion
The present work is focused on the age-related evolution
of the self-immune patterns. Therefore, the characterization
of the nature and structure of identiﬁed antigenic bands
of interest (such as p94) will be assessed in future stud-
ies requiring mass-spectrometry analysis. Their presence
in malaria infection may be of prognostic interest as in
other infections where some auto-antibodies reveal a new
repertoire that heralds susceptibility to future autoimmune
diseases [60]. Self-reactivity to nonerythroid alpha spectrin
and beta tubulin III have been associated with CM in
Gabonese children [38] and Indian populations, respectively
[61]. However, to our knowledge, no speciﬁc brain auto-
antigens related to age of infection with malaria have been
reported until now. It is, therefore, of interest to characterize
such self-antigens because CM is one of the principal causes
of neurodisability in sub-Saharan Africa [62]. Although a
few studies suggest that there is full neurological recovery
in CM [35, 63, 64], it has become clear that many children
have sustained severe brain injury over the past 15 years.
Thus, 25% of CM cases result in long-term neurological and8 Interdisciplinary Perspectives on Infectious Diseases
cognitive deﬁciency or epilepsy [65, 66]. Our data show that
parasite pressure seems to cause quantitative and qualitative
changes of systemic self-IgG immune-reactive proﬁles in
MEI. However, the singularities of such an immune response
related to age allow the identiﬁcation of some speciﬁc
antigenic bands as potent useful biomarkers. Their further
characterization is of particular prognostic interest in CM
since such evolutionary changes involving the repertoires of
self-natural antibodies and acquired antibodies may lead to
pathogenic or protective events [15].
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